Development of fatal tuberculosis in a patient with rheumatoid arthritis after three years of treatment with infliximab: comment on the article by Wolfe et al

被引:5
作者
Molenaar, ETH [1 ]
Bultink, IEM [1 ]
Dijkmans, BAC [1 ]
Lems, WF [1 ]
机构
[1] VU Med Ctr, Slotervaart Hosp, Jan Van Breemen Inst, Amsterdam, Netherlands
来源
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 04期
关键词
D O I
10.1002/art.20973
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1334 / 1336
页数:3
相关论文
共 3 条
[1]   Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent [J].
Keane, J ;
Gershon, S ;
Wise, RP ;
Mirabile-Levens, E ;
Kasznica, J ;
Schwieterman, WD ;
Siegel, JN ;
Braun, MM .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (15) :1098-1104
[2]   High Incidence of Anergy in Inflammatory Bowel Disease Patients Limits the Usefulness of PPD Screening Before Infliximab Therapy [J].
Mow, William S. ;
Abreu-Martin, Maria T. ;
Papadakis, Konstantinos A. ;
Pitchon, Howard E. ;
Targan, Stephan R. ;
Vasiliauskas, Eric A. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (04) :309-313
[3]   Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy [J].
Wolfe, F ;
Michaud, K ;
Anderson, J ;
Urbansky, K .
ARTHRITIS AND RHEUMATISM, 2004, 50 (02) :372-379